International Conference on IP in Biotechnology, Pharmaceuticals, and Life Sciences
ICIPBPLS
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest developments in patent law as they pertain to biotechnology innovations. Participants will discuss the implications of recent legal decisions and legislative changes on patentability and enforcement.
SDG 3
SDG 9
This track focuses on effective intellectual property strategies that pharmaceutical companies can adopt to enhance their competitive edge. Discussions will include portfolio management, patent filing strategies, and risk mitigation.
SDG 3
SDG 9
This session will delve into the intersection of biotech innovation and patent protection mechanisms. Experts will analyze case studies of successful biotech patents and the challenges faced in securing them.
SDG 3
SDG 9
This track will examine the complexities of licensing agreements within the life sciences sector. Participants will discuss best practices for negotiating terms that protect intellectual assets while fostering collaboration.
SDG 8
This session will address the critical role of technology transfer in the commercialization of intellectual property in biotechnology and pharmaceuticals. The discussion will focus on strategies for effective transfer and commercialization processes.
SDG 9
SDG 17
This track will explore the relationship between regulatory compliance and intellectual property rights in the life sciences. Experts will discuss how compliance issues can impact patent strategies and enforcement.
SDG 16
This session will highlight the importance of effective IP management in the biopharmaceutical industry. Attendees will learn about tools and frameworks for managing intellectual assets throughout the product lifecycle.
SDG 9
SDG 17
This track will focus on the enforcement of intellectual property rights specific to the biotechnology sector. Participants will discuss litigation strategies, challenges in enforcement, and the role of international treaties.
SDG 16
This session will cover various strategies for protecting intellectual assets in the life sciences. Experts will share insights on risk assessment and proactive measures to safeguard innovations.
SDG 9
SDG 16
This track will provide a global perspective on innovations in patent law affecting biotechnology and pharmaceuticals. Participants will engage in discussions about differing legal frameworks and their implications for international collaboration.
SDG 9
SDG 17
This session will explore future trends and potential legal challenges in biotechnology law. Experts will discuss the evolving landscape of IP rights and the implications for innovation in the sector.
SDG 9
SDG 16